Proton pump inhibitors: Are we still prescribing them without valid indications?

Australasian Medical Journal

Volumn 7, Issue 11, 2014, Pages 465-470

  Akram, Farooq ^a,b   Huang, Yufang ^b   Lim, Valencia ^b   Huggan, Paul J ^c   Merchant, Reshma A ^a,b  

^a NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c WAIKATO DISTRICT HEALTH BOARD   (New Zealand)

Author keywords

Elderly; Prescribing; Proton pump inhibitors; Valid indications

Indexed keywords

ACETYLSALICYLIC ACID; ESOMEPRAZOLE; HEPARIN; LANSOPRAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR; WARFARIN;

AGED; ARTICLE; DRUG INDICATION; DUODENUM ULCER; FEMALE; GASTRITIS; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL HEMORRHAGE; HELICOBACTER INFECTION; HUMAN; INAPPROPRIATE PRESCRIBING; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; PRESCRIPTION; PREVALENCE; RETROSPECTIVE STUDY; SINGAPORE;

EID: 84913530755     PISSN: None     EISSN: 18361935     Source Type: Journal    
DOI: 10.4066/AMJ.2014.2093     Document Type: Article

References (22)

1. Heidelbaugh J, Kim A, Chang R, Walker P. Overutilization of proton-pump inhibitors: what the clinician needs to know. Therap Adv. Gastroenterol 2012;5:219-32.
2. Eid SM, Boueiz A, Paranji S, Mativo C, Landis R, Abougergi MS. Patterns and predictors of proton pump inhibitor overuse among academic and non-academic hospitalists. Intern Med 2010; 49(23):2561-68.
3. Reid M, Keniston A, Heller JC, Miller M, Medvedev S, Albert RK. Inappropriate Prescribing of Proton Pump Inhibitors in Hospitalized. J Hospital medicine 2012;7(5):421-5.
4. Jarchow-MacDonald AA, Mangoni AA. Prescribing patterns of proton pump inhibitors in older hospitalized patients in a Scottish health board. Geriatr Gerontol Int 2013;13:1002-9.
5. Dial S, Delaney JA, Barkun AN, Suissa S. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile associated disease. JAMA. 2005;294(23):2989-2995.937-944.
6. Eom CS, Jeon CY, Lim JW, Cho EG, Park SM, Lee KS. Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis. CMAJ 2011;183(3):310.
7. Yang YX, Lewis JD, Epstein S, Metz DC. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA 2006; 296(24):2947-2.
8. McColl KE. Effect of proton pump inhibitors on vitamins and iron. Am J Gastroenterol. 2009; 14(Suppl 2):S5-9.
9. Geevasinga N, Coleman PL, Webster AC, Roger SD. Proton pump inhibitors and acute interstitial nephritis. Clin Gastro-enterol Hepatol. 2006;4:597-604.
10. Kahrilas PJ, Shaheen NJ, Vaezi MF. American Gastroenterological Association Institute technical review on the management of gastro-oesophageal reflux disease. Gastroenterology.2008;135:1392-1413.
11. Freston JW. Review article: role of proton pump inhibitors in non-H. Pylori-related ulcers. Aliment Pharmacol Ther 2001;15[Suppl 2]:2-5.
12. Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007;56:772-81.
13. Wilcox CM, Hirschowitz BI. Treatment strategies for Zollinger-Ellison syndrome. Expert Opin Pharmacother 2009;10:1145-1157.
14. Wang WH, Huang JQ, Zheng GF, Xia HH, Wong WM, Liu XG, et al. Effects of proton-pump inhibitors on functional dyspepsia: a meta-analysis of randomized placebo-controlled trials. Clin Gastroenterol Hepatol 2007;5(2):178.
15. Redeen S, Petersson F, Jonsson KA, Borch K. Relationship of gastroscopic features to histological findings in gastritis and Helicobacter pylori infection in a general population sample. Endoscopy 2003;35:946-950.
16. Lanza FL, Chan FK, Quigley EM. Guidelines for Prevention of NSAID-related ulcer complications. Am Gastroenterol 2009;104:728-38.
17. Bhatt DL, Scheiman J, Abraham NS, Antman EM, Chan FK, Furberg CD, et al. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2008;52(18):1502.
18. Batuwitage BT, Kingham JG, Morgan NE, Bartlett RL. Inappropriate prescribing of proton pump inhibitors in primary care. Postgrad Med J. 2007;83(975):66-8.
19. Ahrens D, Chenot JF, Behrens G, Grimmsmann T, Kochen MM. Appropriateness of treatment recommendations for PPI in hospital discharge letters. Eur J Clin Pharmacol 2010;66:1265-71.
20. Haroon M, Yasin F, Gardezi KM, Adeeb F, Walker F. Inappropriate use of proton pump inhibitors among medical inpatients: a questionnaire-based observational study. JRSM Short Rep. 2013 Jun 25;4(8).
21. Lanas A, Perez-Aisa MA, Feu F, Ponce J, Saperas E, Santolaria S, et al. Investigators of the Asociación Española de Gastroenterología (AEG). A nationwide study of mortality associated with hospital admission due to severe gastrointestinal events and those associated with non-steroidal anti-inflammatory drug use. Am J Gastroenterol 2005;100:1685-93.
22. Valkhoff VE, Sturkenboom MC, Kuipers EJ. Risk factors for gastrointestinal bleeding associated with low-dose aspirin. Best Pract Res Clin Gastroenterol. 2012 Apr; 26(2):125-40.